Close Menu

Scary Yet Cool

This New Yorker story looks into synthetic biology, particularly the work of Berkeley's Jay Keasling and Stanford's Drew Endy. Both say that one goal of their work is to make interchangeable parts that can be swapped in and out of a cell — like a hard drive, as Keasling puts it. However, some of what is proposed, namely creating new forms of life or designing children, gives people pause. Why? "Because it's scary as hell," Endy says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.

Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.

The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.

In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.